Browsing Tag
Aurinia Pharmaceuticals
2 posts
Aurinia Pharmaceuticals posts positive Phase 1 data for aritinercept (AUR200) with implications for autoimmune disease treatment
Aurinia Pharmaceuticals reveals strong Phase 1 data for aritinercept (AUR200), signaling promise in autoimmune disease therapeutics. Read full clinical insights.
July 2, 2025
Aurinia Pharmaceuticals to present AUR200 Phase 1 trial data on June 30, 2025 in key webcast update
Aurinia Pharmaceuticals will release AUR200 Phase 1 results on June 30, 2025. Analysts await autoimmune insights. Join the webcast for full trial data.
June 30, 2025